Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease

Annals of the New York Academy of Sciences
Hyoung-Gon LeeMark A Smith

Abstract

Ever since their initial description over a century ago, senile plaques and their major protein component, amyloid-beta, have been considered key contributors to the pathogenesis of Alzheimer disease. However, counter to the popular view that amyloid-beta represents an initiator of disease pathogenesis, we herein challenge dogma and propose that amyloid-beta occurs secondary to neuronal stress and, rather than causing cell death, functions as a protective adaptation to the disease. By analogy, individuals suffering from altitude sickness nearly always have elevated levels of hemoglobin. However, while hemoglobin is toxic to cells in culture and increased erythropoiesis at sea level can be deadly, it is clear that the increases in hemoglobin occurring at altitude are beneficial. Amyloid, like hemoglobin, may also be beneficial, in this case, following neuronal stress or disease. Although controversial, a protective function for amyloid-beta is supported by all of the available literature to date and also explains why many aged individuals, despite the presence of high numbers of senile plaques, show little or no cognitive decline. With this in mind, we suspect that current therapeutic efforts targeted toward lowering amyloid-bet...Continue Reading

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Feb 17, 1998·Trends in Neurosciences·R L Neve, N K Robakis
Apr 28, 1999·Journal of Neuropathology and Experimental Neurology·D G DavisW R Markesbery
Mar 7, 2000·Lancet·G PerryM A Smith
Nov 23, 2000·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Feb 13, 2001·Neurobiology of Aging·J JosephM A Smith
Feb 22, 2001·Free Radical Biology & Medicine·C A RottkampM A Smith
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·A NunomuraM A Smith
Jun 5, 2002·Lancet·Mark A SmithGeorge Perry
Jun 19, 2002·Acta Neuropathologica·Mark A SmithGeorge Perry
Jul 19, 2002·Journal of Neuroscience Research·Mark A SmithGeorge Perry
Sep 13, 2002·Journal of Alzheimer's Disease : JAD·C S AtwoodM A Smith
Oct 26, 2002·Free Radical Biology & Medicine·Mark A SmithGeorge Perry
Dec 10, 2002·Neurobiology of Aging·Mark E ObrenovichMark A Smith
Apr 10, 2003·Free Radical Biology & Medicine·Gerald VeurinkRalph N Martins

❮ Previous
Next ❯

Citations

Aug 27, 2009·Journal of Neural Transmission·Kurt A Jellinger
May 4, 2010·Molecular Neurobiology·Sally A Frautschy, Greg M Cole
Aug 15, 2009·Neurotoxicity Research·Yan-Jiang WangXin-Fu Zhou
Aug 30, 2011·Nature Chemical Biology·Lucy A WoodsSheena E Radford
Nov 28, 2012·Nature Reviews. Neurology·Reisa A SperlingKeith A Johnson
Feb 8, 2011·Metallomics : Integrated Biometal Science·David J BondaMark A Smith
Apr 23, 2009·The Journal of Biological Chemistry·Erez PodolyHermona Soreq
Nov 30, 2006·The Journal of General Physiology·David Eliezer
Nov 30, 2011·Antioxidants & Redox Signaling·Rommy von Bernhardi, Jaime Eugenín
Sep 8, 2005·Rejuvenation Research·Rafal M Smigrodzki, Shaharyar M Khan
Oct 19, 2013·Brain : a Journal of Neurology·Carlos Humberto Andrade-MoraesRoberto Lent
Jun 9, 2005·Alzheimer Disease and Associated Disorders·Kate M WebberMark A Smith
Mar 16, 2006·Drugs & Aging·Hyoung-gon LeeMark A Smith
Feb 19, 2011·International Journal of Alzheimer's Disease·R A Armstrong
May 9, 2014·Neurobiology of Aging·Vanja KljajevicUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 29, 2014·Radiology·Jeffrey W PrescottUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 7, 2014·Journal of Molecular Neuroscience : MN·A G HenriquesO A B da Cruz e Silva
Jan 5, 2011·International Journal of Alzheimer's Disease·Joseph J BraymerMi Hee Lim
Nov 23, 2013·Radiology·Jeffrey R Petrella
Apr 12, 2013·Expert Opinion on Biological Therapy·Haythum O TayebFrank I Tarazi
Jan 23, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Valentina BertiAlberto Pupi
Dec 27, 2011·Pharmacology & Therapeutics·Haythum O TayebFrank I Tarazi
Oct 1, 2015·Brain : a Journal of Neurology·Andre AltmannUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Apr 17, 2010·Neuropharmacology·David J BondaMark A Smith
Mar 5, 2008·Journal of Neurochemistry·Birgit Fogal, Sandra J Hewett
Nov 18, 2006·Brain Research·Wendy M BrooksMike P Starkey
Jul 1, 2006·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Sonia FrancoMark A Smith
Dec 20, 2014·Molecular Neurodegeneration·Felipe G SerranoNibaldo C Inestrosa
Jul 11, 2014·Frontiers in Pharmacology·Rafael Franco, Angel Cedazo-Minguez
Jul 7, 2005·Microbial Pathogenesis·Hervé C GérardAlan P Hudson
Jun 20, 2006·Experimental Neurology·Hyoung-gon LeeMark A Smith
Jan 23, 2009·Free Radical Research·Sandra L SiedlakGeorge Perry
Aug 29, 2006·The American Journal of Pathology·R Lyle PattonAlex E Roher
Aug 29, 2006·The American Journal of Pathology·Hyoung-gon LeeMark A Smith
Nov 13, 2007·Neuroscience·C NocjarS S Shim
Apr 26, 2006·American Journal of Alzheimer's Disease and Other Dementias·Rudy J CastellaniMark A Smith
Jul 29, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Maj S ThomsenTorben Moos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.